VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
2.820
+0.090 (3.30%)
Nov 20, 2024, 4:00 PM EST - Market closed
VYNE Therapeutics Market Cap
VYNE Therapeutics has a market cap or net worth of $41.60 million as of November 21, 2024. Its market cap has increased by 261.33% in one year.
Market Cap
41.60M
Enterprise Value
-28.46M
1-Year Change
261.33%
Ranking
Category
Stock Price
$2.82
Market Cap Chart
Since March 10, 2020, VYNE Therapeutics's market cap has decreased from $229.74M to $41.60M, a decrease of -81.89%. That is a compound annual growth rate of -30.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 41.60M | 27.92% |
| Dec 29, 2023 | 32.52M | 273.57% |
| Dec 30, 2022 | 8.71M | -84.05% |
| Dec 31, 2021 | 54.59M | -79.42% |
| Dec 31, 2020 | 265.25M | 15.46% |
| Mar 10, 2020 | 229.74M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LAVA Therapeutics | 42.08M |
| Intensity Therapeutics | 42.00M |
| Nexalin Technology | 41.82M |
| NeueHealth | 41.27M |
| Anebulo Pharmaceuticals | 40.72M |
| CERo Therapeutics Holdings | 39.88M |
| Rallybio | 39.83M |
| BioLineRx | 39.47M |